Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY | 17-AAG |
FIMM | Tanespimycin |
CTRPv2 | tanespimycin |
PharmacoGx | 17-AAG |
Database | Identifier |
---|---|
Smiles: | CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC |
Inchikey: | AYUNIORJHRXIBJ-TXHRRWQRSA-N |
Pubchem: | 6505803 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C2orf82 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | C19orf43 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | CRYL1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | RSBN1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | WFDC2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | OPTN | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | SYN2 | CCLE | pan-cancer | AAC | -0.22 | 0.0001 |
mRNA | CCL19 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
mRNA | NUDT11 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | RBM12B | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |